Author

Evan R. Lamb

Observed names: Evan Lamb, Evan R Lamb

Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Vaccine Research Center

Observed institutions: University of Iowa, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Vaccine Research Center, University of Virginia

ORCID: 0000-0002-1759-2423

Observed ORCID: 0000-0002-1759-2423

OpenAlex ID: A5102924691

Evaluating vaccine-elicited antibody activities against Neisseria gonorrhoeae : cross-protective responses elicited by the 4CMenB meningococcal vaccine

2023 · Mary C. Gray, Keena S. Thomas, et al. · Infection and Immunity · 12

Cell‐cell communication, chemotaxis and recruitment in Vibrio parahaemolyticus

2019 · Evan Lamb, Michael J. Trimble, et al. · Molecular Microbiology · 11

A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial

2026 · Aurélie Ploquin, Rosemarie D. Mason, et al. · Nature Medicine · 9

Terminal complement complexes with or without C9 potentiate antimicrobial activity against Neisseria gonorrhoeae

2025 · Evan R. Lamb, Alison K. Criss · mBio · 5

Dual species transcriptomics reveals conserved metabolic and immunologic processes in interactions between human neutrophils and Neisseria gonorrhoeae

2024 · Aimee D. Potter, Vonetta L. Edwards, et al. · PLoS Pathogens · 5

High-dimensional spectral flow cytometry of activation and phagocytosis by peripheral human polymorphonuclear leukocytes

2025 · Evan R Lamb, Ian J Glomski, et al. · Journal of Leukocyte Biology · 3

Works count: 7

Citation count: 45

H-index: 5

I10-index: 2